Does bisoprolol reduce the incidence of CHF and/or COPD exacerbation compared with carvedilol in congestive heart failure patients with chronic obstructive pulmonary disease?
Congestive heart failure patients with chronic obstructive pulmonary disease
Bisoprolol
Carvedilol
Incidence of CHF and/or COPD exacerbationcomposite
In patients with concurrent heart failure and COPD, the use of a selective beta-blocker like bisoprolol may be preferable to carvedilol to reduce the incidence of exacerbations.
These findings support the recommendations to use β-blockers in HF patients with COPD. Importantly, bisoprolol reduced the incidence of CHF and/or COPD exacerbation compared with carvedilol.
Building similarity graph...
Analyzing shared references across papers
Loading...
Yoshiaki Kubota
Kubota (Japan)
Kuniya Asai
Heart Failure & Transplant
Erito Furuse
Saiseikai Utsunomiya hospital
International Journal of COPD
Nippon Medical School
Building similarity graph...
Analyzing shared references across papers
Loading...
Kubota et al. (Sun,) studied this question.
synapsesocial.com/papers/69d875b733ca018b39ae3a3e — DOI: https://doi.org/10.2147/copd.s79942
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: